Skip to main content


Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

Fig. 5

Effect of saxagliptin on gene expression of CD34+ (a) and CD34− (b) cells. A low number of CD34+ cells obtained resulted in a reduced amount of mRNA affecting the number of samples suitable for analysis. The genes affected by saxagliptin treatment were: SOD1 (n = 11), GPX1 (n = 11), CASP3 (n = 10), IL6 (n = 13), IGF1 (n = 7). *p < 0.05; **p < 0.01. Results are relative to visit 1 (control)

Back to article page